AbbVie: Shared decision making

Summary

The involvement of patients in decisions about their care is essential to help effectively manage long-term conditions and help achieve the best possible patient outcome. ‘Shared decision making’ ensures that individuals are supported, by their healthcare partners, to make decisions about their care or treatment, that are right for them. Shared decision making is included in the NHS Constitution, and AbbVie, a research-driven biopharmaceutical company. hopes to help continue raising the profile of patient involvement.

AbbVie wants to see shared decision making be widely adopted across NHS services. To support this ambition, AbbVie held the Shared Decision Making Showcase in Parliament on the 10 March 2020. A year on from the publication of the NHS Long Term Plan, and Universalised Personalised Care Plan – which established ambitious targets to put shared decision making at the heart of patient care – the showcase provided a platform for patient groups, NHS Trusts, and healthcare providers to share their innovative work.

The projects showcased ranged from MS, arthritis, Lymphoma, Autism, Hepatitis C, kidney dialysis and more—all focused on empowering patients to take an active part in decisions about their treatment and care.

AbbVie has supported a number of organisations and projects to develop and enable shared decision making including two of the showcased initiatives: a survey of treatment decision experience amongst psoriasis patients and the work of the Patient Information Forum to develop and implement the Perfect Patient Information Journey.